TGFBR1, mFc Chimera, Avi, Human
TGFBR1, MFc Chimera, Avi, Human

The purity of TGFBR1, mFc Chimera, Avi, Human is greater than 95% as determined by SEC-HPLC.

TGFBR1, MFc Chimera, Avi, Human

TGFBR1, mFc Chimera, Avi, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

TGFBR1, mFc Chimera, Avi, Human

transforming growth factor beta receptor 1 (TGFBR1), a key stimulator of tumor proliferation and metastasis, was a direct target of miR‑98‑5p. miR‑98‑5p overexpression resulted in the downregulation of TGFBR1 and the suppression of the viability, proliferation, migration and invasion of A549 and H1299 cells.
Z05874
¥69,021.00

Ask us a question
Product Introduction
Species Human
Protein Construction
TGFBR1 (Leu34-Glu125)_x000D_
Accession # P36897-1		 mFc (IgG1) Avi
N-term C-term
Purity > 95% as determined by Bis­Tris PAGE 
> 95% as determined by HPLC
Endotoxin Level Less than 1EU per μg by the LAL method.
Expression System HEK293
Theoretical Molecular Weight 38.2 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 50-55 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles.

Examples
  • TGFBR1, MFc Chimera, Avi, Human
    • TGFBR1, MFc Chimera, Avi, Human

    The purity of TGFBR1, mFc Chimera, Avi, Human is greater than 95% as determined by SEC-HPLC.

  • TGFBR1, MFc Chimera, Avi, Human
    • TGFBR1, MFc Chimera, Avi, Human

    TGFBR1, mFc Chimera, Avi, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.


Background
Target Background transforming growth factor beta receptor 1 (TGFBR1), a key stimulator of tumor proliferation and metastasis, was a direct target of miR‑98‑5p. miR‑98‑5p overexpression resulted in the downregulation of TGFBR1 and the suppression of the viability, proliferation, migration and invasion of A549 and H1299 cells.
Synonyms AAT5; ACVRLK4; ALK-5; ALK5; LDS1A; LDS2A; SKR4; tbetaR-I; TGFB1R1; TGF-beta RI; TGFbetaRI; TGFBR1; TGF-bRI; TGFR-1; tβR-I; TGF-β RI; TGFβRI

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.